Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section
A Prospective Randomized Controlled Trial Comparing Restrictive and Liberal Intraoperative Fluid Strategies on Postoperative Nausea and Vomiting and Gastrointestinal Recovery After Elective Cesarean Section Under Spinal Anesthesia
1 other identifier
interventional
160
1 country
1
Brief Summary
Spinal anesthesia for elective cesarean section is frequently associated with hemodynamic instability and postoperative complications such as postoperative nausea and vomiting (PONV) and delayed gastrointestinal recovery. Although intraoperative fluid administration is routinely used to prevent spinal-induced hypotension, the optimal fluid strategy remains unclear. Both restrictive and liberal fluid approaches may influence maternal hemodynamics and postoperative outcomes through different physiological mechanisms. This prospective, single-center, randomized controlled trial aims to compare restrictive (≤3 mL/kg/h) and liberal (\>3 mL/kg/h) intraoperative crystalloid fluid strategies in patients undergoing elective cesarean section under spinal anesthesia. The primary outcome is the incidence of PONV within the first 24 hours postoperatively. Secondary outcomes include postdural puncture headache (PDPH), time to first flatus, hypotension frequency, and vasopressor requirements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedStudy Start
First participant enrolled
March 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 30, 2027
March 10, 2026
March 1, 2026
11 months
February 23, 2026
March 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of postoperative nausea and vomiting (PONV)
Occurrence of nausea and/or vomiting within the first 24 hours after surgery, recorded as present or absent.
0-24 hours postoperatively
Secondary Outcomes (4)
Incidence and severity of postdural puncture headache (PDPH)
24-72 hours postoperatively
Time to first flatus
Up to 72 hours postoperatively
Frequency of intraoperative hypotension
Intraoperative period
Total intraoperative vasopressor dose
Intraoperative period
Study Arms (2)
Restrictive intraoperative fluid strategy (≤3 mL/kg/h)
EXPERIMENTALParticipants undergoing elective cesarean section under spinal anesthesia will receive intraoperative crystalloid at a target average infusion rate of ≤3 mL/kg/h. Standardized spinal anesthesia technique and intraoperative management will be applied. Hypotension will be treated according to the predefined rescue protocol (e.g., ephedrine and/or additional fluid bolus as clinically indicated).
Liberal intraoperative fluid strategy (>3 mL/kg/h)
ACTIVE COMPARATORParticipants undergoing elective cesarean section under spinal anesthesia will receive intraoperative crystalloid at a target average infusion rate of \>3 mL/kg/h. Standardized spinal anesthesia technique and intraoperative management will be applied. Hypotension will be treated according to the predefined rescue protocol (e.g., ephedrine and/or additional fluid bolus as clinically indicated).
Interventions
Intraoperative crystalloid administration targeting an average rate of ≤3 mL/kg/h during elective cesarean section under spinal anesthesia.
Intraoperative crystalloid administration targeting an average rate of \>3 mL/kg/h during elective cesarean section under spinal anesthesia.
Eligibility Criteria
You may qualify if:
- Female patients aged 18-45 years
- ASA physical status II
- Scheduled for elective cesarean section under spinal anesthesia
- Provision of written informed consent
You may not qualify if:
- Emergency cesarean section
- Preeclampsia or eclampsia
- Known cardiac failure
- Known renal failure
- Known hepatic failure
- Coagulopathy
- Contraindication to spinal anesthesia
- Conversion to general anesthesia
- Major technical complications during spinal anesthesia
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Niğde Ömer Halisdemir University Hospital
Niğde, Merkez, 51240, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pınar Erdoğan, Assoc Prof
Niğde Ömer Halisdemir University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will be blinded to group allocation. The anesthesia team will not be blinded due to the nature of the intervention (intraoperative fluid strategy). Postoperative outcomes will be collected by a blinded assessor who is not involved in intraoperative care and has no access to allocation information. Group allocation will be recorded in a separate study log and concealed from participants and outcome assessors until completion of follow-up.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 23, 2026
First Posted
February 27, 2026
Study Start
March 4, 2026
Primary Completion (Estimated)
January 30, 2027
Study Completion (Estimated)
January 30, 2027
Last Updated
March 10, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared due to institutional policies and ethical considerations related to patient confidentiality. De-identified data may be made available upon reasonable request to the corresponding investigator, subject to approval by the institutional ethics committee and data protection regulations.